IL266495B - Derivatives of aminoglycosides, preparations containing them and their use for the treatment of genetic diseases - Google Patents

Derivatives of aminoglycosides, preparations containing them and their use for the treatment of genetic diseases

Info

Publication number
IL266495B
IL266495B IL266495A IL26649519A IL266495B IL 266495 B IL266495 B IL 266495B IL 266495 A IL266495 A IL 266495A IL 26649519 A IL26649519 A IL 26649519A IL 266495 B IL266495 B IL 266495B
Authority
IL
Israel
Prior art keywords
aminoglycosides
genetic disorders
treating genetic
treating
disorders
Prior art date
Application number
IL266495A
Other languages
English (en)
Hebrew (he)
Other versions
IL266495A (en
Inventor
Atia-Glikin Dana
Kandasamy Jeyakumar
Belakhov Valery
Baasov Timor
Original Assignee
Technion Res & Dev Foundation
Dana Atia Glikin
Kandasamy Jeyakumar
Belakhov Valery
Baasov Timor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technion Res & Dev Foundation, Dana Atia Glikin, Kandasamy Jeyakumar, Belakhov Valery, Baasov Timor filed Critical Technion Res & Dev Foundation
Publication of IL266495A publication Critical patent/IL266495A/en
Publication of IL266495B publication Critical patent/IL266495B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D79/00—Kinds or details of packages, not otherwise provided for
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/228—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings
    • C07H15/23—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings with only two saccharide radicals in the molecule, e.g. ambutyrosin, butyrosin, xylostatin, ribostamycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Mechanical Engineering (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL266495A 2010-11-18 2019-05-07 Derivatives of aminoglycosides, preparations containing them and their use for the treatment of genetic diseases IL266495B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41495610P 2010-11-18 2010-11-18
PCT/IL2011/000889 WO2012066546A1 (en) 2010-11-18 2011-11-17 Aminoglycosides and uses thereof in treating genetic disorders

Publications (2)

Publication Number Publication Date
IL266495A IL266495A (en) 2019-07-31
IL266495B true IL266495B (en) 2020-09-30

Family

ID=45390144

Family Applications (3)

Application Number Title Priority Date Filing Date
IL266495A IL266495B (en) 2010-11-18 2019-05-07 Derivatives of aminoglycosides, preparations containing them and their use for the treatment of genetic diseases
IL277063A IL277063B (en) 2010-11-18 2020-09-01 Derivatives of aminoglycosides, preparations containing them and their use for the treatment of genetic diseases
IL284067A IL284067B (en) 2010-11-18 2021-06-16 Derivatives of aminoglycosides, preparations containing them and their use for the treatment of genetic diseases

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL277063A IL277063B (en) 2010-11-18 2020-09-01 Derivatives of aminoglycosides, preparations containing them and their use for the treatment of genetic diseases
IL284067A IL284067B (en) 2010-11-18 2021-06-16 Derivatives of aminoglycosides, preparations containing them and their use for the treatment of genetic diseases

Country Status (18)

Country Link
US (7) US8895519B2 (enExample)
EP (2) EP3296311B1 (enExample)
JP (3) JP5960712B2 (enExample)
CA (1) CA2816789C (enExample)
CY (1) CY1120082T1 (enExample)
DK (1) DK2640734T3 (enExample)
ES (2) ES2655916T3 (enExample)
HR (1) HRP20180056T1 (enExample)
HU (1) HUE036248T2 (enExample)
IL (3) IL266495B (enExample)
LT (1) LT2640734T (enExample)
NO (1) NO2640734T3 (enExample)
PL (1) PL2640734T3 (enExample)
PT (1) PT2640734T (enExample)
RS (1) RS56739B1 (enExample)
SI (1) SI2640734T1 (enExample)
SM (1) SMT201800019T1 (enExample)
WO (1) WO2012066546A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE036248T2 (hu) 2010-11-18 2018-06-28 Technion Res & Dev Foundation Aminoglükozidok és alkalmazásaik genetikai rendellenességek kezelésére
KR101703137B1 (ko) 2014-05-30 2017-02-07 선문대학교 산학협력단 당 부가 아미노글리코사이드 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
EP3151840A1 (en) * 2014-06-05 2017-04-12 Eloxx Pharmaceuticals Ltd. Use of aminoglycoside analogs in the treatment of rett syndrome
HK1257935A1 (zh) * 2015-09-02 2019-11-01 Eloxx Pharmaceuticals Ltd. 氨基糖苷衍生物及其在治疗遗传性病症中的应用
EP3344640A4 (en) * 2015-09-02 2019-05-01 Eloxx Pharmaceuticals Ltd. AMINO-LIKES DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF GENETIC DISEASES
WO2017037718A1 (en) * 2015-09-02 2017-03-09 Eloxx Pharmaceuticals Ltd. Aminoglycoside derivatives and uses thereof in treating genetic disorders
WO2017118968A1 (en) * 2016-01-05 2017-07-13 Eloxx Pharmaceuticals Ltd. Aminoglycoside derivatives and uses thereof in treating genetic disorders
JP7187471B2 (ja) * 2017-03-15 2022-12-12 エロックス ファーマシューティカルズ リミテッド 擬似三糖アミノグリコシドおよびその中間体の大規模調製
WO2019237076A1 (en) * 2018-06-07 2019-12-12 Eloxx Pharmaceuticals, Inc. Methods, compositions, and kits for inducing readthrough
KR102067477B1 (ko) * 2018-06-20 2020-01-17 고려대학교 산학협력단 스킬로이노사민을 포함하는 아미노사이클리톨 화합물, 이의 제조방법 및 이를 함유하는 약학 조성물
WO2020113124A1 (en) * 2018-11-29 2020-06-04 Eloxx Pharmaceuticals Methods, compositions, and kits for treating ocular diseases
WO2021061873A1 (en) * 2019-09-23 2021-04-01 Eloxx Pharmaceuticals, Inc. Methods, compositions, and kits for treating polycystic kidney disease
EP4230196A1 (en) 2022-02-21 2023-08-23 Som Innovation Biotech, S.A. Compounds for use in the treatment of dystrophinopathies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5960712A (ja) 1982-09-30 1984-04-06 Toshiba Corp デ−タ判別装置
JP5830213B2 (ja) 2004-02-17 2015-12-09 ザ ホスピタル フォー シック チルドレン Ｍｅｃｐ２ｅ１遺伝子
LT2390255T (lt) * 2006-04-03 2016-10-25 Technion Research & Development Foundation Ltd. Nauji aminoglikozidai ir jų panaudojimas genetinių sutrikimų gydyme
HUE036248T2 (hu) * 2010-11-18 2018-06-28 Technion Res & Dev Foundation Aminoglükozidok és alkalmazásaik genetikai rendellenességek kezelésére
EP3151840A1 (en) * 2014-06-05 2017-04-12 Eloxx Pharmaceuticals Ltd. Use of aminoglycoside analogs in the treatment of rett syndrome

Also Published As

Publication number Publication date
WO2012066546A1 (en) 2012-05-24
US20190224226A9 (en) 2019-07-25
US9616079B2 (en) 2017-04-11
US20210228608A1 (en) 2021-07-29
NO2640734T3 (enExample) 2018-03-17
CA2816789A1 (en) 2012-05-24
SI2640734T1 (en) 2018-02-28
EP2640734A1 (en) 2013-09-25
US20170182078A1 (en) 2017-06-29
IL266495A (en) 2019-07-31
PT2640734T (pt) 2018-01-22
HUE036248T2 (hu) 2018-06-28
IL284067B (en) 2022-03-01
SMT201800019T1 (it) 2018-03-08
CA2816789C (en) 2018-12-11
IL284067A (en) 2021-07-29
ES2833938T3 (es) 2021-06-16
US11865128B2 (en) 2024-01-09
JP2018123135A (ja) 2018-08-09
HK1248709A1 (en) 2018-10-19
JP5960712B2 (ja) 2016-08-02
US9943533B2 (en) 2018-04-17
US9175029B2 (en) 2015-11-03
JP2016121168A (ja) 2016-07-07
US20180200276A1 (en) 2018-07-19
IL277063A (en) 2020-10-29
LT2640734T (lt) 2018-02-12
US20130237489A1 (en) 2013-09-12
JP6758338B2 (ja) 2020-09-23
DK2640734T3 (en) 2018-01-22
US10398718B2 (en) 2019-09-03
JP2013542981A (ja) 2013-11-28
CY1120082T1 (el) 2018-12-12
PL2640734T3 (pl) 2018-04-30
US20140357590A1 (en) 2014-12-04
US20160074425A1 (en) 2016-03-17
EP2640734B1 (en) 2017-10-18
ES2655916T3 (es) 2018-02-22
HRP20180056T1 (hr) 2018-02-09
US20200078386A1 (en) 2020-03-12
EP3296311A1 (en) 2018-03-21
US10973839B2 (en) 2021-04-13
EP3296311B1 (en) 2020-09-30
IL277063B (en) 2021-07-29
US8895519B2 (en) 2014-11-25
RS56739B1 (sr) 2018-03-30

Similar Documents

Publication Publication Date Title
IL284067B (en) Derivatives of aminoglycosides, preparations containing them and their use for the treatment of genetic diseases
EP2632490A4 (en) NOVEL MOLECULES BINDING TO THE EGF RECEPTOR AND IMMUNOCONJUGATES THEREOF
ZA201207574B (en) Phytocannabinoids in the treatment of cancer
IL229541B (en) Petridine compounds and their uses for the treatment of autoimmune diseases
GB201010557D0 (en) RNA molecules and uses thereof
IL221511A (en) Arilatriazolones associated with bis aryl and their use
IL227678B (en) Triterpenoids that have undergone a structural change in positions 3 and 17
ZA201208173B (en) Peptices and their use
GB201120993D0 (en) Novel compounds and their use in therapy
IL236098A0 (en) Different fibronectin fragments or variants and uses thereof
EP2707756A4 (en) REMOVAL OF REAL AMPLITUDE LAYERS IN FRACTURED MEDIA
PT2790739T (pt) Nanopartículas e utilizações das mesmas
IL226108B (en) Mimochromes containing metals and their uses in chemistry and biology
GB0912744D0 (en) Methods and uses
GB201718726D0 (en) Phytocannabinoids in the treatment of cancer
GB0818663D0 (en) Gene regulation and its use in therapy
IL226390A0 (en) Derivatives of aminoglycosides, preparations containing them and their use for the treatment of genetic diseases
GB0900329D0 (en) Improvements in anti-ligature devices and methods
IL230474B (en) Lactoferrin segments and their uses
AU2012266896A1 (en) Scaffold-kinase interaction blockades and uses thereof in treating cancer
GB201004608D0 (en) Improvements in and to processes
GB201001384D0 (en) Light-fitting and associated methods
GB201018131D0 (en) 2 and 3 new poker
GB201117876D0 (en) Peptides and their use in treatment
GB201021105D0 (en) Improvements in and relating to parathas

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed